Lunit scores deal to support early breast cancer screening NSW

South Korean AI company Lunit has become BreastScreen NSW’s machine reading solution of choice for early breast cancer detection.

THAT’S what it’s about

BSNSW is part of the national BreastScreen Australia Program which aims to improve survival rates for women with breast cancer. It offers free mammograms for women age 40 and older to detect breast cancer early.

A year after tendering, the Cancer Institute NSW, which runs the BreastScreen program in NSW, has selected Lunit’s proposal to supply its Lunit INSIGHT MMG. The AI-based technology is capable of analyzing mammograms with 96% accuracy.

Before using the solution, the Cancer Institute NSW will first validate the Lunit INSIGHT MMG to confirm its potential clinical benefit. About 650,000 mammograms will be used to test and compare readings from the AI ​​solution to historical reports from BSNSW radiologists.

Later, the expected validation of the technology will be done by evaluating approximately 240,000 tests over an eight-month period.

After this, the mammography analysis solution will be rolled out and incorporated into the BSNSW PACS environment to assist radiologists in screening tests. In this final phase, it will still be validated for clinical use.

It is only after completing all initial implementation phases that Lunit will be awarded a five-year operating contract with the Cancer Institute NSW.


The BSNWS contract, which is Lunit’s first contract for national breast screening, will allow the company to support screening tests for around 350,000 women each year.

“This is the first time Lunit has had the opportunity to provide our AI solution for a national breast screening system. We plan to proactively prepare for the rapidly growing demand in national screening programs around the world, as well as actively seek new business opportunities,” said Brandon Suh, director of Lunit.


Lunit INSIGHT MMG already supports other free breast screenings. The Egypt’s Baheya Foundation aims to use AI technology to help screen about 500,000 women each year.

The mammography device, along with Lunit Insight CXR, an artificial intelligence solution for mammography, has also been picked up by the private Bumrungrad International Hospital in Thailand and most recently by SEHA, the largest healthcare system in the United Arab Emirates.

Leave a Comment

Your email address will not be published. Required fields are marked *